On Monday, Organogenesis Holdings Inc (NASDAQ: ORGO) opened lower -2.45% from the last session, before settling in for the closing price of $3.06. Price fluctuations for ORGO have ranged from $2.28 to $6.71 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 14.32% over the past five years. Company’s average yearly earnings per share was noted 650.00% at the time writing. With a float of $64.40 million, this company’s outstanding shares have now reached $126.85 million.
Let’s look at the performance matrix of the company that is accounted for 869 employees. In terms of profitability, gross margin is 74.32%, operating margin of -0.27%, and the pretax margin is -0.58%.
Organogenesis Holdings Inc (ORGO) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Drug Manufacturers – Specialty & Generic industry is another important factor to consider. The insider ownership of Organogenesis Holdings Inc is 49.24%, while institutional ownership is 47.98%. The most recent insider transaction that took place on Mar 04 ’25, was worth 127,000. Before that another transaction happened on Mar 04 ’25, when Company’s Director sold 25,000 for $5.10, making the entire transaction worth $127,535. This insider now owns 166,879 shares in total.
Organogenesis Holdings Inc (ORGO) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 650.00% per share during the next fiscal year.
Organogenesis Holdings Inc (NASDAQ: ORGO) Trading Performance Indicators
Check out the current performance indicators for Organogenesis Holdings Inc (ORGO). In the past quarter, the stock posted a quick ratio of 3.67. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.83.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.15, a number that is poised to hit -0.04 in the next quarter and is forecasted to reach 0.15 in one year’s time.
Technical Analysis of Organogenesis Holdings Inc (ORGO)
Organogenesis Holdings Inc (NASDAQ: ORGO) saw its 5-day average volume 3.66 million, a positive change from its year-to-date volume of 1.86 million. As of the previous 9 days, the stock’s Stochastic %D was 29.42%. Additionally, its Average True Range was 0.47.
During the past 100 days, Organogenesis Holdings Inc’s (ORGO) raw stochastic average was set at 2.87%, which indicates a significant decrease from 3.21% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 235.60% in the past 14 days, which was higher than the 160.98% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.68, while its 200-day Moving Average is $3.57. Nevertheless, the first resistance level for the watch stands at $3.21 in the near term. At $3.43, the stock is likely to face the second major resistance level. The third major resistance level sits at $3.55. If the price goes on to break the first support level at $2.87, it is likely to go to the next support level at $2.76. The third support level lies at $2.53 if the price breaches the second support level.
Organogenesis Holdings Inc (NASDAQ: ORGO) Key Stats
There are currently 126,854K shares outstanding in the company with a market cap of 378.66 million. Presently, the company’s annual sales total 482,040 K according to its annual income of 860 K. Last quarter, the company’s sales amounted to 126,660 K and its income totaled 7,670 K.
